165 related articles for article (PubMed ID: 31620453)
1. Conventional-Vincristine Sulfate vs. Modified Protocol of Vincristine Sulfate and L-Asparaginase in Canine Transmissible Venereal Tumor.
Setthawongsin C; Teewasutrakul P; Tangkawattana S; Techangamsuwan S; Rungsipipat A
Front Vet Sci; 2019; 6():300. PubMed ID: 31620453
[No Abstract] [Full Text] [Related]
2. The role of the multi-drug resistance 1, p53, b cell lymphoma 2, and bcl 2-associated X genes in the biologic behavior and chemotherapeutic resistance of canine transmissible venereal tumors.
Alzate JM; Montoya-Florez LM; Pérez JE; Rocha NS; Pedraza-Ordonez FJ
Vet Clin Pathol; 2019 Dec; 48(4):730-739. PubMed ID: 31777108
[TBL] [Abstract][Full Text] [Related]
3.
Setthawongsin C; Tangkawattana S; Rungsipipat A; Techangamsuwan S
Front Vet Sci; 2019; 6():104. PubMed ID: 31024941
[No Abstract] [Full Text] [Related]
4. Intratumoral recombinant human interferon alpha-2a and vincristine combination therapy in canine transmissible venereal tumour.
Kanca H; Tez G; Bal K; Ozen D; Alcigir E; Atalay Vural S
Vet Med Sci; 2018 Nov; 4(4):364-372. PubMed ID: 30117719
[TBL] [Abstract][Full Text] [Related]
5. Vincristine and ivermectin combination chemotherapy in dogs with natural transmissible venereal tumor of different cyto-morphological patterns: A prospective outcome evaluation.
Ferreira Bulhosa L; Estrela-Lima A; da Silva Solcà M; Diniz Gonçalves GS; Larangeira DF; de Pinho FA; Barrouin-Melo SM
Anim Reprod Sci; 2020 May; 216():106358. PubMed ID: 32414469
[TBL] [Abstract][Full Text] [Related]
6.
Franco Molina MA; Santamaría-Martínez EA; Santana Krimskaya SE; Zarate-Triviño DG; Kawas JR; Ramos Zayas Y; Palacios Estrada N; Prado García H; García Coronado PL; Rodríguez Padilla C
Front Vet Sci; 2022; 9():972185. PubMed ID: 36061122
[TBL] [Abstract][Full Text] [Related]
7. Vincristine-associated total antioxidant and oxidant status of ovaries and in vitro nuclear oocyte maturation in dogs with canine transmissible venereal tumor.
Özalp GR; Üstüner B; Avci G; Bari Ö; Yılmaz MM; Denk B; Aktar A
Anim Reprod Sci; 2023 Jun; 253():107260. PubMed ID: 37196377
[TBL] [Abstract][Full Text] [Related]
8. Cell-mediated immunity and expression of MHC class I and class II molecules in dogs naturally infected by canine transmissible venereal tumor: Is there complete spontaneous regression outside the experimental CTVT?
do Prado Duzanski A; Flórez LMM; Fêo HB; Romagnoli GG; Kaneno R; Rocha NS
Res Vet Sci; 2022 Jul; 145():193-204. PubMed ID: 35240476
[TBL] [Abstract][Full Text] [Related]
9. Factor Analysis for Bicluster Acquisition (FABIA) revealed vincristine-sensitive transcript pattern of canine transmissible venereal tumors.
Chokeshaiusaha K; Puthier D; Nguyen C; Sudjaidee P; Sananmuang T
Heliyon; 2019 May; 5(5):e01558. PubMed ID: 31193204
[TBL] [Abstract][Full Text] [Related]
10. Combination therapy using intratumoral bacillus Calmette-Guerin (BCG) and vincristine in dogs with transmissible venereal tumours: therapeutic efficacy and histological changes.
Mukaratirwa S; Chitanga S; Chimatira T; Makuleke C; Sayi ST; Bhebhe E
J S Afr Vet Assoc; 2009 Jun; 80(2):92-6. PubMed ID: 19831270
[TBL] [Abstract][Full Text] [Related]
11. Fibrosis in canine transmissible venereal tumor after chemotherapy with vincristine.
Duzanski ADP; Feo HB; Montoya Flórez LM; Dinau FC; Paiva BR; Brandão CVS; Rocha NS
Braz J Vet Med; 2023; 45():e000123. PubMed ID: 37146075
[TBL] [Abstract][Full Text] [Related]
12. Effect of tumor infiltrating lymphocytes on the expression of MHC molecules in canine transmissible venereal tumor cells.
Hsiao YW; Liao KW; Hung SW; Chu RM
Vet Immunol Immunopathol; 2002 Aug; 87(1-2):19-27. PubMed ID: 12052339
[TBL] [Abstract][Full Text] [Related]
13. Autologous canine immunotherapy: short-time generated dendritic cells loaded with canine transmissible venereal tumor-whole lysate.
Franco-Molina MA; Ramos-Zayas Y; Coronado-Cerda EE; Mendoza-Gamboa E; Zapata-Benavides P; Santana-Krymskaya SE; Tamez-Guerra R; Rodríguez-Padilla C
Immunopharmacol Immunotoxicol; 2018 Oct; 40(5):437-443. PubMed ID: 30507311
[TBL] [Abstract][Full Text] [Related]
14. Canine transmissible venereal tumor: First report of three clinical cases from Tripoli, Libya.
Hiblu MA; Khabuli NM; Gaja AO
Open Vet J; 2019 Jul; 9(2):103-105. PubMed ID: 31360646
[TBL] [Abstract][Full Text] [Related]
15. Computerized Cytomorphometric and Cytomorphological Analysis of Canine Transmissible Venereal Tumours.
Setthawongsin C; Tangkawattana S; Rungsipipat A; Techangamsuwan S
J Comp Pathol; 2018 Aug; 163():18-22. PubMed ID: 30213369
[TBL] [Abstract][Full Text] [Related]
16. Neutropenia associated with vincristine and L-asparaginase induction chemotherapy for canine lymphoma.
Northrup NC; Rassnick KM; Snyder LA; Stone MS; Kristal O; Cotter SM; Moore AS
J Vet Intern Med; 2002; 16(5):570-5. PubMed ID: 12322708
[TBL] [Abstract][Full Text] [Related]
17. Predictive factors for the regression of canine transmissible venereal tumor during vincristine therapy.
Scarpelli KC; Valladão ML; Metze K
Vet J; 2010 Mar; 183(3):362-3. PubMed ID: 19109042
[TBL] [Abstract][Full Text] [Related]
18. Canine transmissible venereal tumor and seminoma: a cytohistopathology and chemotherapy study of tumors in the growth phase and during regression after chemotherapy.
Javanbakht J; Pedram B; Taheriyan MR; Khadivar F; Hosseini SH; Abdi FS; Hosseini E; Moloudizargari M; Aghajanshakeri SH; Javaherypour S; Shafiee R; Emrani Bidi R
Tumour Biol; 2014 Jun; 35(6):5493-500. PubMed ID: 24557542
[TBL] [Abstract][Full Text] [Related]
19. Epidemiological study of canine transmissible venereal tumor (CTVT) in Brazil, 2000-2020.
Pimentel PAB; Oliveira CSF; Horta RS
Prev Vet Med; 2021 Dec; 197():105526. PubMed ID: 34740024
[TBL] [Abstract][Full Text] [Related]
20. Presence of Papillomavirus DNA sequences in the canine transmissible venereal tumor (CTVT).
Ayala-Díaz S; Jiménez-Lima R; Ramírez-Alcántara KM; Lizano M; Castro-Muñoz LJ; Reyes-Hernández DO; Arroyo-Ledezma J; Manzo-Merino J
PeerJ; 2019; 7():e7962. PubMed ID: 31667018
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
